resTORbio
Boston
About resTORbio
resTORbio is a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for the treatment of aging-related diseases.The Company develops medicines and therapies to treat aging-related diseases and conditions such as cancer, heart disease, neurodegenerative diseases, and diabetes mellitus. resTORbio serves clients in the State of Massachusetts.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Public
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $115.0M
- Funding stage: IPO
- Last round: Post-IPO Equity (Mar 2019)
- Ticker: nasdaq:TORC
- Website: restorbio.com
- Phone: 857-315-5528
Industries & Categories
Biopharma, Biotechnology, Clinical Trials, Medical
Social Profiles
Canonical: https://fsome.com/organization/restorbio-2229401 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.